Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05852925 · ClinicalTrials.gov registry record · NA

Evaluation of Tasso+ Blood Self-Collection for Clinical Diagnostic Assessment of Various Biomarkers

A NA study of Blood Self-Collection for Clinical Diagnostic Assessments, sponsored by American Research Labs.

Recruiting
Registry status
NA
Development phase
2,500
Enrollment target
1
Study location

NCT05852925 is a NA study of Blood Self-Collection for Clinical Diagnostic Assessments that is actively recruiting participants, run by American Research Labs. The registered enrollment target is 2,500 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05852925, a NA study of Blood Self-Collection for Clinical Diagnostic Assessments, is actively recruiting participants, sponsored by American Research Labs.

RECRUITING
Registry status
NA
Development phase
2,500 participants
Enrollment target
1
Study location

Study Summary

This study aims to assess the effectiveness and reliability of the Tasso+ capillary blood self-collection device in the clinical diagnostic assessment of various biomarkers. The study will collect blood specimens using both the Tasso+ self-collection device and traditional venipuncture. The biomarker analysis results from both specimen types will be compared for correlation.

Interventions

  • OTHER Traditional Venipuncture
  • DEVICE Tasso+

Study Locations (1)

Florida

  • American Research Labs - Atlantis

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2023-07-25
Est. Completion 2026-07
Phase NA

Sponsor

American Research Labs

1 total trials

What the Registry Record Tells You About NCT05852925

The ClinicalTrials.gov registry entry for NCT05852925 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Research Labs, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood Self-Collection for Clinical Diagnostic Assessments appearing as the primary indexed condition, and to 2 interventions - of which Traditional Venipuncture is the first listed.

NCT05852925 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05852925 about?

NCT05852925 is a clinical study titled "Evaluation of Tasso+ Blood Self-Collection for Clinical Diagnostic Assessment of Various Biomarkers". This study aims to assess the effectiveness and reliability of the Tasso+ capillary blood self-collection device in the clinical diagnostic assessment of various biomarkers. The study will collect blood specimens using both the Tasso+ self-collection device and traditional venipuncture. The biomarke...

What is the current status of trial NCT05852925?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,500 participants. The study started on 2023-07-25. Estimated completion is 2026-07.

What conditions does trial NCT05852925 study?

This clinical trial studies the following conditions: Blood Self-Collection for Clinical Diagnostic Assessments.

What interventions are being tested in trial NCT05852925?

The interventions under investigation include: Traditional Venipuncture (OTHER), Tasso+ (DEVICE).

Who is sponsoring clinical trial NCT05852925?

This trial is sponsored by American Research Labs, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05852925 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.